Intermedin/adrenomedullin-2 inhibits growth hormone release from cultured, primary anterior pituitary cells

Endocrinology

Volumn 147, Issue 2, 2006, Pages 859-864

  Taylor, Meghan M ^a   Bagley, Sara L ^a   Samson, Willis K ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN 2; AMYLIN; CALCITONIN GENE RELATED PEPTIDE; CORTICOTROPIN; CYCLIC AMP; GROWTH HORMONE; INTERMEDIN; PEPTIDE DERIVATIVE; PROLACTIN; PROTIRELIN; SOMATOSTATIN; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE INHIBITION; HYPOPHYSIS CELL; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; PROTEIN FAMILY; PROTEIN FUNCTION; RAT; STATISTICAL SIGNIFICANCE;

ADRENOCORTICOTROPIC HORMONE; ADRENOMEDULLIN; ANIMALS; CELLS, CULTURED; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GROWTH HORMONE; MALE; NEUROPEPTIDES; PITUITARY GLAND, ANTERIOR; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 30944435085     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0949     Document Type: Article

References (23)

1. Roh J, Chang CL, Bhalla A, Klein C, Hsu SYT 2004 Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complex. J Biol Chem 279:7264-7274
2. Takei Y, Hyodo S, Katafuchi T, Minamino N 2004 Novel fish-derived adrenomedullin in mammals: structure and possible function. Peptides 25:1643-1656
3. Takei Y, Inoue K, Ogoshi M, Kawahara T, Bannai H, Miyano S 2004 Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett 556:53-58
4. Taylor MM, Bagley SL, Samson WK 2005 Intermedin/adrenomedullin-2 acts within the central nervous system to elevate blood pressure and inhibit food and water intake. Am J Physiol 288:R919-R927
5. Dumont Y, Chabot J, Quirion R 2004 Receptor autoradiography as a means to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides. Peptides 25:365-391
6. Morley JE, Farr SA, Flood JF 1996 Peripherally administered calcitonin gene-related peptide decreases food intake in mice. Peptides 17:511-516
7. Murphy TC, Samson WK 1995 The novel vasoactive hormone, adrenomedullin, inhibits water drinking in the rat. Endocrinology 136:2459-2463
8. Samson WK, Said SI, Snyder G, McCann SM 1979 In vitro stimulation of prolactin release by vasoactive intestinal peptide. Peptides 1:325-332
9. Epelbaum J, Enjalbert A, Krantic S, Musset F, Bertrand P, Rasolonjanabary R, Shu C and Kordon C 1987 Somatostatin receptors on pituitary somatotrophs, thyrotrophs, and lactotrophs: pharmacological evidence for loose coupling to adenylate cyclase. Endocrinology 121:2177-2185
10. Taylor MM, Samson WK 2005 Stress hormone secretion is altered by central administration of intermedin/adrenomedullin 2. Brain Res 1045:199-205
11. Taylor MM, Samson WK 2004 A mechanism for the action of adrenomedullin in brain to stimulate stress hormone secretion. Endocrinology 145:4890-4896
12. Fahim A, Retori V, McCann SM 1990 The role of calcitonin gene-related peptide in the control of growth hormone and prolactin release. Neuroendocrinology 51:688-693
13. Iino K, Oki Y, Tominaga T, Iwabuchi M, Ozawa M, Watanabe F, Yoshimi T 1998 Stimulatory effects of calcitonin gene-related peptide on adrenocorticotropin release from rat anterior pituitary cells. J Neuroendocrinol 10:325-329
14. Nakamura Y, Shimatsu A, Murabe H, Mizuta H, Ihara C, Nakao K 1998 Calcitonin gene-related peptide as a GH secretagogue in human and rat pituitary somatotrophs. Brain Res 807:203-207
15. Nakamura Y, Shimatsu A, Murabe H, Mizuta H, Ihara C, Nakao K 1998 Calcitonin gene-related peptide (CGRP) as GH secretagogue in rat and human pituitary tumoral cells. Endocr J 45:S89-S91
16. Netti C, Sibilia V, Pagani F, Lattuada N, Coluzzi M, Pecile A, Guidobono F 1995 Inhibitory effect of amylin on growth hormone responsiveness to growth-hormone-releasing hormone in the rat. Neuroendocrinology 62:313-318
17. Pagani F, Netti C, Guidobono F, Lattuada N, Ticozzi C, Sibilia V 1998 Effects of amylin and salmon calcitonin on B-endorphin-induced growth hormone and prolactin secretion in the rat. Neuroendocrinology 68:220-228
18. Shah G, Expand R, Orlowski R 1988 Calcitonin inhibition of prolactin secretion in isolated rat pituitary cells. J Endocrinol 116:279-286
19. Koch Y, Lu KH, Meites J 1970 Biphasic effects of catecholamines on pituitary prolactin release in vitro. Endocrinology 87:673-675
20. Samson WK, Taylor MM 2001 Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Am J Physiol 281:R1140-R1145
21. Vale W, Vaughan J, Smith M, Yamamoto G, Rivier J, Rivier C 1983 Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides and other substances on cultured corticotropic cells. Endocrinology 113:1121-1131
22. Wu JT, Kral JG 2004 Ghrelin: integrative neuroendocrine peptide in health and disease. Ann Surg 239:464-474
23. Stratakis CA, Chrousos GP 1997 Hypothalamic hormones. In: Conn PM, Melmed S, eds. Endocrinology, basic and clinical principles. Totowa, NJ: Humana Press; 185-209